Department of Neurosurgery, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea.
J Korean Med Sci. 2013 Jun;28(6):939-45. doi: 10.3346/jkms.2013.28.6.939. Epub 2013 Jun 3.
This study was done to evaluate whether injections of resveratrol, a natural compound found in the skin of grapes, had anabolic effects on degenerated intervertebral discs in a rabbit model. Two non-continuous lumbar discs were punctured in rabbits to induce disc degeneration. Four weeks and 6 weeks after puncture, the rabbits were treated by injections with dimethylsulfoxide (DMSO) or resveratrol. At 4, 8, and 16 weeks after initial injection, rabbits were sacrificed and the spine was extracted for magnetic resonance image (MRI), mRNA expression, and histological staining. Resveratrol treatment resulted in stronger signal intensity in T2-weighted images. MRI grade showed significantly lower in the resveratrol group than the DMSO group (P = 0.039). In the resveratrol group, aggrecan gene expression was significantly increased than that in the DMSO group at 16 weeks after injection (P = 0.027). MMP-13 mRNA levels in the resveratrol group were significantly decreased than those in the DMSO group at 8 and 16 weeks (P = 0.006 and P = 0.048, respectively). In hematoxylin and eosin stain, resveratrol-treated discs showed the features of regeneration. Histologic grade revealed improvement in resveratrol-treated discs, compared with DMSO-treated discs (P = 0.024). These anabolic effects on degenerated discs indicate that resveratrol is a promising candidate for treatment of degenerative disc disease.
本研究旨在评估白藜芦醇(一种存在于葡萄皮中的天然化合物)注射是否对兔模型退变的椎间盘具有合成代谢作用。通过穿刺两只非连续的腰椎间盘来诱导椎间盘退变。穿刺后 4 周和 6 周,用二甲基亚砜(DMSO)或白藜芦醇进行注射治疗。初次注射后 4、8 和 16 周,处死兔子并提取脊柱进行磁共振成像(MRI)、mRNA 表达和组织学染色。白藜芦醇治疗组的 T2 加权图像信号强度更强。MRI 分级显示白藜芦醇组明显低于 DMSO 组(P=0.039)。在白藜芦醇组,与注射后 16 周的 DMSO 组相比,聚集蛋白聚糖基因表达显著增加(P=0.027)。白藜芦醇组的 MMP-13 mRNA 水平在 8 周和 16 周时均明显低于 DMSO 组(P=0.006 和 P=0.048)。苏木精-伊红染色显示白藜芦醇治疗的椎间盘具有再生特征。组织学分级显示白藜芦醇治疗的椎间盘与 DMSO 治疗的椎间盘相比有所改善(P=0.024)。这些对退变椎间盘的合成代谢作用表明白藜芦醇是治疗退行性椎间盘疾病的有前途的候选药物。